Adis Journals
Browse
- No file added yet -

Cost-Effectiveness Analysis of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Metastatic Colorectal Cancer in the USA

Download (89.84 kB)
figure
posted on 2021-02-03, 17:20 authored by Adis journals on behalf of, Shuosha Li, Huabin Hu, Dong Ding, Youwen Zhu, Jin Huang

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    BinimetinibBRAF V600E mutationCetuximabCost-effectivenessEncorafenibMetastatic colorectal cancer

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC